149 related articles for article (PubMed ID: 37005758)
1. Heat Shock Proteins in Non-Small-Cell Lung Cancer-Functional Mechanism.
Zhou G; Pu Y; Zhao K; Chen Y; Zhang G
Front Biosci (Landmark Ed); 2023 Mar; 28(3):56. PubMed ID: 37005758
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein antagonists in early stage clinical trials for NSCLC.
Hendriks LEL; Dingemans AC
Expert Opin Investig Drugs; 2017 May; 26(5):541-550. PubMed ID: 28274158
[TBL] [Abstract][Full Text] [Related]
3. Harnessing mitochondrial metabolism and drug resistance in non-small cell lung cancer and beyond by blocking heat-shock proteins.
Parma B; Wurdak H; Ceppi P
Drug Resist Updat; 2022 Dec; 65():100888. PubMed ID: 36332495
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 72 does not modulate ionizing radiation-induced apoptosis in U1810 non-small cell lung carcinoma cells.
Ekedahl J; Joseph B; Marchetti P; Fauvel H; Formstecher P; Lewensohn R; Zhivotovsky B
Cancer Biol Ther; 2003; 2(6):663-9. PubMed ID: 14688473
[TBL] [Abstract][Full Text] [Related]
5. Activation of the HSP27-AKT axis contributes to gefitinib resistance in non-small cell lung cancer cells independent of EGFR mutations.
Choi SK; Kim M; Lee H; Kwon Y; Cha HJ; Jang SJ; Na Y; Lee YS
Cell Oncol (Dordr); 2022 Oct; 45(5):913-930. PubMed ID: 35931945
[TBL] [Abstract][Full Text] [Related]
6. Luteolin is effective in the non-small cell lung cancer model with L858R/T790M EGF receptor mutation and erlotinib resistance.
Hong Z; Cao X; Li N; Zhang Y; Lan L; Zhou Y; Pan X; Shen L; Yin Z; Luo L
Br J Pharmacol; 2014 Jun; 171(11):2842-53. PubMed ID: 24471765
[TBL] [Abstract][Full Text] [Related]
7. Ginkgo biloba extract decreases non-small cell lung cancer cell migration by downregulating metastasis-associated factor heat-shock protein 27.
Tsai JR; Liu PL; Chen YH; Chou SH; Yang MC; Cheng YJ; Hwang JJ; Yin WH; Chong IW
PLoS One; 2014; 9(3):e91331. PubMed ID: 24618684
[TBL] [Abstract][Full Text] [Related]
8. Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting.
Parma B; Ramesh V; Gollavilli PN; Siddiqui A; Pinna L; Schwab A; Marschall S; Zhang S; Pilarsky C; Napoli F; Volante M; Urbanczyk S; Mielenz D; Schrøder HD; Stemmler M; Wurdak H; Ceppi P
J Exp Clin Cancer Res; 2021 Aug; 40(1):248. PubMed ID: 34364401
[TBL] [Abstract][Full Text] [Related]
9. Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and Chemotherapy.
Lelj-Garolla B; Kumano M; Beraldi E; Nappi L; Rocchi P; Ionescu DN; Fazli L; Zoubeidi A; Gleave ME
Mol Cancer Ther; 2015 May; 14(5):1107-16. PubMed ID: 25740245
[TBL] [Abstract][Full Text] [Related]
10. Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential.
Wang C; Zhang Y; Guo K; Wang N; Jin H; Liu Y; Qin W
Int J Cancer; 2016 Apr; 138(8):1824-34. PubMed ID: 26853533
[TBL] [Abstract][Full Text] [Related]
11. Polyphyllin I promotes cell death via suppressing UPR-mediated CHOP ubiquitination and degradation in non-small cell lung cancer.
Liu MM; Zhu ML; Dong RF; Zhang C; Zhang H; Yang L; Kong LY; Xia YZ
Chin J Nat Med; 2021 Apr; 19(4):255-266. PubMed ID: 33875166
[TBL] [Abstract][Full Text] [Related]
12. LKB1 inactivation sensitizes non-small cell lung cancer to pharmacological aggravation of ER stress.
Inge LJ; Friel JM; Richer AL; Fowler AJ; Whitsett T; Smith MA; Tran NL; Bremner RM
Cancer Lett; 2014 Oct; 352(2):187-95. PubMed ID: 25011082
[TBL] [Abstract][Full Text] [Related]
13. Targeting heat shock proteins in cancer.
Jego G; Hazoumé A; Seigneuric R; Garrido C
Cancer Lett; 2013 May; 332(2):275-85. PubMed ID: 21078542
[TBL] [Abstract][Full Text] [Related]
14. Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in Cancer.
Saini J; Sharma PK
Curr Drug Targets; 2018; 19(13):1478-1490. PubMed ID: 28831912
[TBL] [Abstract][Full Text] [Related]
15. Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non-small cell lung cancer.
Bao R; Lai CJ; Wang DG; Qu H; Yin L; Zifcak B; Tao X; Wang J; Atoyan R; Samson M; Forrester J; Xu GX; DellaRocca S; Borek M; Zhai HX; Cai X; Qian C
Mol Cancer Ther; 2009 Dec; 8(12):3296-306. PubMed ID: 19952121
[TBL] [Abstract][Full Text] [Related]
16. The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells.
Sieger KA; Mhashilkar AM; Stewart A; Sutton RB; Strube RW; Chen SY; Pataer A; Swisher SG; Grimm EA; Ramesh R; Chada S
Mol Ther; 2004 Mar; 9(3):355-67. PubMed ID: 15006602
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Afatinib Treatment in Non-small Cell Lung Cancer Cells.
Pancewicz-Wojtkiewicz J; Bernatowicz PL
Anticancer Res; 2017 Jul; 37(7):3543-3546. PubMed ID: 28668844
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
[TBL] [Abstract][Full Text] [Related]
19. Systems pharmacology unravels the synergic target space and therapeutic potential of Rhodiola rosea L. for non-small cell lung cancer.
Zhang X; Zhu J; Yan J; Xiao Y; Yang R; Huang R; Zhou J; Wang Z; Xiao W; Zheng C; Wang Y
Phytomedicine; 2020 Dec; 79():153326. PubMed ID: 32992083
[TBL] [Abstract][Full Text] [Related]
20. Heat shock proteins as biomarkers of lung cancer.
Mittal S; Rajala MS
Cancer Biol Ther; 2020 Jun; 21(6):477-485. PubMed ID: 32228356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]